Reumatología

2022

1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

   Seminars in Arthritis and Rheumatism, Vol. 52

2. Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review

   Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436

3. Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients

   Seminars in Arthritis and Rheumatism, Vol. 57

4. Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study

   Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224

5. Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis

   Frontiers in Medicine, Vol. 9

6. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

   Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

7. Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients

   Seminars in Arthritis and Rheumatism, Vol. 55

8. Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

   Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3817-3823

9. Gout. What's up doc?

   Medicina Clinica, Vol. 158, Núm. 12, pp. 615-621

10. Heart Transplantation in Systemic Sclerosis: A Therapeutic Option. Presentation of a Case and Literature Review

    Reumatologia Clinica, Vol. 18, Núm. 6, pp. 374-376

11. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

    Arthritis Care and Research, Vol. 74, Núm. 10, pp. 1649-1658

12. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

    Journal of Clinical Medicine, Vol. 11, Núm. 19

13. Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain

    Rheumatology International, Vol. 42, Núm. 10, pp. 1819-1829

14. Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review

    Seminars in Arthritis and Rheumatism, Vol. 52

15. Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis

    Frontiers in Immunology, Vol. 13

16. Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis

    Clinical and experimental rheumatology, Vol. 40, Núm. 5, pp. 975-979

17. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

    RMD Open, Vol. 8, Núm. 2

18. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology

    Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259

19. One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

    Arthritis Research and Therapy, Vol. 24, Núm. 1

20. Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases

    Joint Bone Spine, Vol. 89, Núm. 1